News
TyraTech Secures New Composition Patent for Human and Animal Health
16 October 2012
Patent Protects New Human and Animal Health Products and Pipeline.
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, is pleased to announce that the Company has received notice from the United States Patent and Trademark Office granting a new patent for the Company's novel anti-parasitic and pest control composition.
The Directors of the Company believe that this patent is an important addition to TyraTech's intellectual property portfolio as it protects a number of new product offerings, including its new head lice flea and tick formulations. It will provide immediate support for TyraTech's head lice treatment range, as the Company plans to launch its first product in this area in 2013. This patent will also provide support and protection of the Company's pipeline of flea and tick control solutions for companion and production animals.
Alan Reade, Executive Chairman of the Company said, "This new addition to our intellectual property portfolio further confirms TyraTech as an innovative human and animal health company. This patent, in particular, provides protection and creates an array of exciting human and animal health market opportunities. Additionally, it validates our position at the forefront of developing best in class solutions that deliver the highest levels of efficacy and safety for people, pets, and production animals."
The issuance of this patent raises TyraTech's patent portfolio to twelve United States and international patents protecting its proprietary screening platform and compositions.
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
Tel: +1 919 415 4310
Peter Jerome, Chief Financial Officer
Tel: +1 919 415 4280
N+1 Brewin, Nominated Adviser and Joint Broker
Aubrey Powell / Robert Beenstock / Alex Wright
Tel: +44 20 3201 3170
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.